Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa K Dunnwald

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nuclear Medicine and Biology|October 17, 2002
[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flowDavid A Mankoff, Lisa K Dunnwald, Julie R Gralow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2003
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapyDavid A Mankoff, Lisa K Dunnwald, Julie R Gralow, et al.
Cancer|January 8, 2005
Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survivalLisa K Dunnwald, Julie R Gralow, Georgiana K Ellis, et al.
Academic Radiology|September 16, 2008
Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancerPeter R Eby, Savannah C Partridge, Steven W White, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2011
Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PETBrenda F Kurland, Lanell M Peterson, Jean H Lee, et al.
Breast Cancer Research and Treatment|February 3, 2007
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)Jennifer M Specht, Stephen L Tam, Brenda F Kurland, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 30, 2010
Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancerSavannah C Partridge, Risa K Vanantwerp, Robert K Doot, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 18, 2002
Detection of locoregional and distant recurrences in breast cancer patients by using FDG PETWilliam B Eubank, David A Mankoff, Hubert J Vesselle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptakeLisa K Dunnwald, Robert K Doot, Jennifer M Specht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancerJennifer M Specht, Brenda F Kurland, Susan K Montgomery, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nuclear Medicine and Biology|October 17, 2002
[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flowDavid A Mankoff, Lisa K Dunnwald, Julie R Gralow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2003
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapyDavid A Mankoff, Lisa K Dunnwald, Julie R Gralow, et al.
Cancer|January 8, 2005
Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survivalLisa K Dunnwald, Julie R Gralow, Georgiana K Ellis, et al.
Academic Radiology|September 16, 2008
Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancerPeter R Eby, Savannah C Partridge, Steven W White, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2011
Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PETBrenda F Kurland, Lanell M Peterson, Jean H Lee, et al.
Breast Cancer Research and Treatment|February 3, 2007
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)Jennifer M Specht, Stephen L Tam, Brenda F Kurland, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 30, 2010
Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancerSavannah C Partridge, Risa K Vanantwerp, Robert K Doot, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 18, 2002
Detection of locoregional and distant recurrences in breast cancer patients by using FDG PETWilliam B Eubank, David A Mankoff, Hubert J Vesselle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptakeLisa K Dunnwald, Robert K Doot, Jennifer M Specht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancerJennifer M Specht, Brenda F Kurland, Susan K Montgomery, et al.
Pageof 3